Document is current

Any future updates will be listed below

Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany

Crossref DOI link: https://doi.org/10.1186/s13023-022-02548-7

Published Online: 2022-10-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark